Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ)
CNY 8.61
(1.41%)
CNY 8.61
(1.41%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 351.11 Million CNY | 267.41% |
| 2022 | 95.56 Million CNY | 252.38% |
| 2021 | 27.11 Million CNY | -34.91% |
| 2020 | 41.66 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 398.1 Million CNY | 15.13% |
| 2024 Q2 | 368.17 Million CNY | -7.52% |
| 2023 Q4 | 351.11 Million CNY | -5.43% |
| 2023 Q1 | 90.15 Million CNY | -5.66% |
| 2023 Q2 | 116.72 Million CNY | 29.47% |
| 2023 Q3 | 371.26 Million CNY | 218.08% |
| 2023 FY | 351.11 Million CNY | 267.41% |
| 2022 Q1 | 23.3 Million CNY | -14.07% |
| 2022 FY | 95.56 Million CNY | 252.38% |
| 2022 Q4 | 95.56 Million CNY | 22.31% |
| 2022 Q3 | 78.13 Million CNY | 93.31% |
| 2022 Q2 | 40.42 Million CNY | 73.44% |
| 2021 FY | 27.11 Million CNY | -34.91% |
| 2021 Q4 | 27.11 Million CNY | -24.84% |
| 2021 Q3 | 36.08 Million CNY | -7.05% |
| 2021 Q2 | 38.81 Million CNY | -6.46% |
| 2021 Q1 | 41.5 Million CNY | -0.38% |
| 2020 FY | 41.66 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q4 | 41.66 Million CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |